IDEXX Laboratories, Inc.
IDXX
$430.12
$1.090.25%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.84% | 6.56% | 6.35% | 7.10% | 8.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.84% | 6.56% | 6.35% | 7.10% | 8.81% |
| Cost of Revenue | 2.18% | 3.25% | 3.68% | 3.86% | 9.25% |
| Gross Profit | 8.46% | 8.77% | 8.08% | 9.23% | 8.50% |
| SG&A Expenses | 9.69% | -21.39% | 3.57% | 10.82% | 6.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.53% | -4.70% | 4.76% | 7.32% | 9.01% |
| Operating Income | 6.68% | 32.73% | 9.85% | 6.62% | 8.29% |
| Income Before Tax | 6.98% | 11.58% | -9.40% | 10.38% | 12.41% |
| Income Tax Expenses | -10.87% | 18.70% | -9.62% | 11.68% | 10.09% |
| Earnings from Continuing Operations | 11.12% | 9.71% | -9.34% | 10.06% | 12.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.12% | 9.71% | -9.34% | 10.06% | 12.96% |
| EBIT | 6.68% | 32.73% | 9.85% | 6.62% | 8.29% |
| EBITDA | 7.40% | 31.31% | 10.34% | 6.52% | 7.75% |
| EPS Basic | 12.81% | 10.77% | -8.84% | 9.92% | 12.75% |
| Normalized Basic EPS | 8.60% | 35.83% | 12.72% | 10.24% | 12.20% |
| EPS Diluted | 13.41% | 10.67% | -8.61% | 10.20% | 12.09% |
| Normalized Diluted EPS | 8.78% | 36.05% | 12.90% | 10.38% | 12.25% |
| Average Basic Shares Outstanding | -1.49% | -0.95% | -0.55% | 0.13% | 0.19% |
| Average Diluted Shares Outstanding | -1.66% | -1.12% | -0.70% | 0.00% | 0.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
